Home/ Stocks/ KALA

KALA BIO, Inc. Common Stock

KALA XNAS

$0.21 -0.02 (-7.00%) ▼ 15-min delayed

Open

$0.23

High

$0.24

Low

$0.21

Volume

3.77M

Market Cap

$212.07M

About KALA BIO, Inc. Common Stock

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 38 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q3 2025	$0	$-7,564,000	$-1.07
Q2 2025	$0	$-11,155,000	$-1.71
Q1 2025	$0	$-8,947,000	$-1.41
FY 2024	$0	$-38,511,000	$-10.15

Earnings & Analyst Ratings

Next Earnings: Tue, May 12, 2026

Calendar →

Related Market News

No specific coverage for KALA yet. Check out our latest market news or earnings calendar.

Get KALA Alerts

Stay ahead with breaking news, price alerts, and expert analysis on KALA BIO, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.